Latest Threads

Al Salam Bank has partnered with Y. K. Almoayyed & Sons to offer a special promotion for its clients, valid until October 26, 2025. The offer includes a 10% discount on electronics and household appliances, along with a one-year extended warranty at YKA's showrooms in Manama and Gudaibiya. Clients can also use the Bank's "Buy Now, Pay Later" service for flexible payment options. This initiative is part of the Bank's commitment to enhancing the client experience and complements an ongoing offer with Eskan Bank, which provides competitive rates for home furnishing in specific projects. The collaboration aims to provide valuable deals and convenient payment solutions for clients.

Press contacts for SHUAA Capital psc include Adnan Nur, the Finance Director. He can be reached at +971 4 610 8206 or via email at sr@shuaa.com. More information can be found on their website, www.shuaa.com.

GFH Financial Group B.S.C. announced details of its liquidity providing activities for December 2024, in compliance with the Central Bank of Bahrain's requirements for monthly disclosures by listed companies. The activities were conducted by liquidity providers SICO in Bahrain Bourse, and BHM Capital in Dubai Financial Market and Abu Dhabi Securities Exchange. As of December 31, 2024, GFH's treasury shares amounted to 258,642,186 shares, representing 6.75% of the group's total outstanding shares. In Bahrain Bourse, SICO purchased 744,434 securities and sold 53,859 securities, with total payments of USD 243,089 and total receipts of USD 17,647.

Globalpharma, a leading pharmaceutical company in the UAE and a subsidiary of Dubai Investments PJSC, plans to launch 25 new products in 2025 across therapeutic areas such as diabetes, cardiovascular, gastroenterology, and orthopaedics. This initiative is part of Globalpharma's strategy to provide high-quality and accessible medications to meet regional healthcare needs. The company aims to strengthen its distribution network and form new partnerships to ensure product accessibility and meet the needs of healthcare practitioners and patients. Globalpharma's focus for 2025 includes innovation, accessibility, and partnerships, building on the success of previous product launches in 2024. The company's efforts align with Dubai Investments' vision to transform key industries and establish a strong presence in the global pharmaceutical sector.

On January 7, 2025, a new series of equity futures contracts, effective from January 9, 2025, will be available for trading. These contracts, set to expire on April 17, 2025, include futures on various securities such as AIRARB, ANSRI, ARMX, DEWA, DEYAAR, DFM, DFMGI, DIB, DIC, DU, EMAAR, EMPWR, EMRDEV, ENBD, GFH, SALIK, and SHUAA. This announcement can be accessed on the Dubai Financial Market's website. Note that the information provided is subject to change, and the Dubai Financial Market's Regulated Derivative Contract Trading Regulation will take precedence in case of any discrepancies.